What does BANS mean in MEDICAL
BANs, or British Approved Names, are terms developed by the Medicines and Healthcare products Regulatory Agency (MHRA) for medications used in the United Kingdom. These medication names are unique to each drug item and appear on a product's label or packaging. BANs consist of the active ingredient(s), strength, pharmaceutical form, and an additional suffix that helps to differentiate drugs from one another. This standardized naming system, which is also known as the Anatomical Therapeutic Chemical (ATC) classification system, has been adopted globally since 1975 and provides a consistent way to identify medications across regions.
BANs meaning in Medical in Medical
BANs mostly used in an acronym Medical in Category Medical that means British Approved Names
Shorthand: BANs,
Full Form: British Approved Names
For more information of "British Approved Names", see the section below.
Essential Questions and Answers on British Approved Names in "MEDICAL»MEDICAL"
What is a BAN?
A British Approved Name (BAN) is the official name by which a medicinal product or ingredient is submitted and accepted for marketing authorisation in the UK. These names are derived from generic, chemical, trade or brand names. The Medicines and Healthcare products Regulatory Agency (MHRA) maintain a list of approved BANs for medicines used in the UK.
How do I find a BAN?
You can find BANs by searching the MHRA’s database of approved medicines at www.mhra.gov.uk/medicines . Alternatively, manufacturers often provide further information on their own websites or databases which list different versions marketed in different countries for a particular drug or ingredient.
Who decides what a BAN should be?
The MHRA has responsibility to decide what constitutes an acceptable British Approved Name (BAN). The MHRA will consult with manufacturers and their vocabulary advisors during this process to agree on appropriate terminology as part of the evaluation process prior to granting approval of a new medicine under European Union law.
Are there regulations regarding how drugs/ingredients should be labelled?
Yes, all medical products containing active pharmaceutical ingredients must comply with EU legislation on labelling – Directive 2001/83/EC - in order to be legally sold within Europe. This requires all drugs and ingredients to include information concerning its Indication, Minimum Age Suitability, Dosage Form and Active Ingredients Listing as well as specific instructions for usage.
Are there differences between brand names and BANS?
Yes, usually brand names are developed by pharmaceutical companies as proprietary names associated with marketing campaigns while British Approved Names (BANS) are simply scientific descriptions designed to distinguish one drug from another. Generic medicines contain only the active substance specified in its corresponding British Approved Name (BAN). Brand name medications may also include additional non-active substances such as dyes or preservatives that make them appear different in colour or taste than generic versions but otherwise have no therapeutic effect.
Is there any penalty if I use incorrect medicinal product labelling?
Yes, incorrect labelling of medicinal products carries financial penalties under Section 64(1)(a) of the Human Medicines Regulations 2012 which states that "No person may supply in contravention of this regulation any medicinal product bearing incorrect information about either the content or identity thereof."
How often does the MHRA update the list of BANs?
The MHRA regularly reviews newly approved medicines and updates its list of approved British Approved Names according to any changes made to them by manufacturers. As such it is important that care givers stay up-to-date on developments in medication terminology especially when dispensing prescribed medication.
Final Words:
Britain's medicinal regulation scheme is known as BANS—British Approved Names System—where every drug is assigned a distinctively unique name that includes its active ingredients, strength, dosage formula, as well as an additional suffix that distinguishes it from other content-similar substances. This allows healthcare professionals quick access to pertinent information needed when dealing with patients’ medicines. The BAN system has been adopted internationally since 1975; significantly increasing medical product safety worldwide through standardized labeling guidelines.
BANs also stands for: |
|
| All stands for BANS |